Skip to main content
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Калтетан форте, 458,4 mg/ml + 125 mg/ml + 20 mg/ml инфузионен разтвор за коне
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu għal ġol-vini

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Forma farmaċewtika:
  • Soluzzjoni għall-infużjoni
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Cattle
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QA12AX
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Bulgaria
Available in:
  • Bulgaria
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Awtorità responsabbli:
  • Bulgarian Food Safety Authority
Numru tal-awtorizzazzjoni:
  • 0022-3110
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • PL/V/0110/002

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
Bulgarian (PDF)
Ippubblikat fuq: 21/07/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."